OGN vs SPIR · P/E 3.4, rev $6.40B vs rev $110.5M
Organon & Co (OGN) versus Spire Global Inc (SPIR) — a side-by-side from cached financials, not a winner call.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Spire Global Inc (SPIR) is a specialty business services company listed on US.
Latest reported OGN revenue for 2024-12-31 was $6.40B. Net income was $864.0M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Latest reported SPIR revenue for 2024-12-31 was $110.5M. Net income was -$102.8M. Revenue was up 13.2% from 2023-12-31 to 2024-12-31. SPIR currently screens at market cap $351.2M.
OGN currently screens at market cap $2.52B and trailing P/E 3.4. SPIR currently screens at market cap $351.2M.
Not investment advice. Open the OGN and SPIR stock pages for the full models.
Not investment advice.